| abstract |
The present invention relates to compounds of general formula (I), and their pharmaceutically acceptable salts and solvates, in the formula Ar, Z and Y are as defined in the description and R1 is a group of the structure, n being 0 or 1 ; R2 represents H, deuterium or methyl; R3 represents methyl, trilluoromethyl, ethyl, or taken together with R2 forms a cyclopropyl group, or together with R3 forms a methylene bridge at the labeled carbon atom *, said compounds according to the invention are suitable for the treatment of autoimmune diseases. immune and chronic inflammation. |